for the period ended 31 March 2006; currency in US Dollars EASTAMPTON, NJ, May 30 /CNW/ - Epicore BioNetworks Inc. reports the results of its third quarter of fiscal 2006 operations. Sales in the quarter were $743,628, a 47% increase from quarter two, which follows the expected seasonal pattern. Sales were 7% lower than prior year quarter three ($743,600 versus $798,700). Gross margin decreased from $562,700 to $517,700. Expenses at $344,900 were 11% above prior year quarter three. The Company recorded a net income of $164,800 versus net income of $251,400 in prior year quarter three. Net income per share for the current quarter was $0.007 versus $0.011 in prior year quarter three. Sales for the quarter reflected the Company's commitment to aquaculture and its strong position in the Latin American market. Fiscal quarter three historically is the Company's strongest. The shrimp aquaculture industry is predominately located in the northern hemisphere so is most active in January to March as customers prepare for the season. In quarter three 2005 Epicore had strong sales in most markets. In 2006 Brazil experienced severe disease problems so bought far less than expected. Distributor realignment in Vietnam contributed to the shortfall. Strong sales in Latin American pond sector covered most of the missed sales. Mexico was our largest sales region with very strong pond product sales. Using a feed treatment approach Ecuador also had strong pond sales. Epicore's EPICIN probiotic protected crops from loss to disease and gave large yield increases compared to untreated ponds. Sales to Asia hatcheries increased 30% compared to 2005 quarter three. Asian sales were dominated by sales in India, where Epicore has an excellent distributor and in Thailand, where our algae growth media is a big success. Gross margin decreased by $0.05 million due to lower sales volume. The quality of business as measured by margin percentage was similar to prior year (70% versus 71%). Quarterly operating expenses were higher than prior period ($344,800 versus $309,800) due to increased marketing activity, especially in Ecuador and Asia. Also, a non-recurring research charge was booked in the quarter. Cost control in non-marketing areas remains an operating priority with a salary reduction program in place for senior employees. Cash at the end of March was $0.25 million, a 9% decrease compared to prior year quarter three. While market conditions remain difficult in several regions, the Company has positioned itself well to succeed in the important markets. After a long period of consolidation in very difficult circumstances, a revitalized management team is looking to move forward more aggressively on a number of fronts to develop value for shareholders accordingly. The financial statements of the Company have been prepared in accordance with US GAAP. Reconciliation with Canadian GAAP may be found in the filed quarterly financial statements. Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.)
Epicore 2006 Third Quarter Results
Epicore BioNetworks Inc on 6ix
Story so far
Earlier from Epicore BioNetworks
- Epicore 2006 Second Quarter Results for the period ended 31 December 2005; currency in US Dollars
- Epicore 2006 First Quarter Results for the period ended 30 September 2005; currency in US Dollars
- Epicore BioNetworks Inc. Fiscal Year 2005 Results for the period ended 30 June 2005
Later from Epicore BioNetworks
- Epicore Appoints New Director
- Epicore Acquires Eastampton Site
- Epicore Signs Letter of Intent with IONA Contractors Ltd.
- Epicore BioNetworks Inc. Fiscal Year 2006 Results for the period ended 30 June 2006
- Epicore BioNetworks Inc. Abandons IONA Acquisition
Follow Epicore BioNetworks into a list and get an email when it puts out news.
Follow Epicore BioNetworks